Skip directly to site content Skip directly to page options Skip directly to A-Z link


Centers for Disease Control and Prevention. CDC twenty four seven. Saving Lives, Protecting People
														Search
		×
			NIOSH
			NIOSH
				All CDC
				Submit
			For a full list of topics:A-Z Index
			Advanced Search
		Advanced Search


The National Institute for Occupational Safety and Health (NIOSH)


Facebook
        Twitter
        LinkedIn
        Syndicate





n-PROPYL NITRATE								Related Pages
										*OSHA comments from the January 19, 1989 Final Rule on Air Contaminants Project extracted from 54FR2332 et. seq. This rule was remanded by the U.S. Circuit Court of Appeals and the limits are not currently in force.*
**CAS:** 627-13-4; **Chemical Formula:** CH3CH2CH2ONO2
OSHA formerly had an 8-hour TWA limit of 25 ppm for n-propyl nitrate. The ACGIH has a 25-ppm TWA and a 15-minute STEL of 40 ppm; these limits were proposed by OSHA. NIOSH (Ex. 8-47) concurred with these proposed limits, and these limits are established in the final rule. n-Propyl nitrate is a pale yellow liquid with a sickly sweet odor.
Rats inhaling propyl nitrate vapor for four hours at a concentration of 10,000 ppm exhibited cyanosis and methemoglobinemia before they died (Hood 1953, as cited in ACGIH 1986/Ex. 1-3, p. 505). The intravenous LD(50) in unanesthetized rabbits has been reported to be between 200 and 250 mg/kg; in anesthetized dogs and cats, intravenous doses of between 100 and 200 mg/kg were usually fatal (Murtha, Stabile, and Wills 1956/Ex. 1-649). Murtha and associates (1956/Ex. 1-649), who conducted these studies, concluded that n-propyl nitrate exerts a direct action on the vascular smooth muscle and that the ensuing cardiac effects and respiratory depression contribute to the compound’s hypotensive action (Murtha, Stabile, and Wills 1956/Ex. 1-649). Inhalation trials in mice, rats, hamsters, guinea pigs, and dogs have established 4-hour LC(50) values ranging from 9000 to 10,000 ppm for rats, 6000 to 7000 ppm for mice, and 2000 to 2500 ppm for dogs. Dogs survived repeated exposures (six hours/day, five days/week) at 260 ppm for six months, although slight clinical signs were observed during the first two weeks of exposure (Rinehart, Garbers, Greene, and Stoufer 1958/Ex. 1-524). The percutaneous toxicity of n-propyl nitrate is low but may cause inflammation and thickening of the skin after repeated exposures; these effects are sometimes transient (ACGIH 1986/Ex. 1-3, p. 505). To protect against cardiovascular and respiratory depressant effects requires both TWA and STEL limits. NIOSH (Ex. 8-47) was the only commenter to the rulemaking record for this substance.
In the final rule, OSHA is retaining the PEL of 25 ppm TWA and adding a STEL of 40 ppm for n-propyl nitrate. The Agency concludes that this combined PEL-STEL limit will protect workers against the significant risk of cyanosis, methemoglobinemia, and hypotension, all material health impairments are potentially associated with exposure to n-propyl nitrate at levels above the 8-hour TWA PEL.
										
							
								Page last reviewed:  September 28, 2011						Content source:  	National Institute for Occupational Safety and Health NIOSH
1988 OSHA PEL Project Documentation
Index of Chemical Names
Index of CAS Numbers Follow NIOSH Facebook
Pinterest
Twitter
YouTube
 NIOSH Homepage NIOSH A-Z
Workplace Safety & Health Topics
Publications and Products
Programs
Contact NIOSH


About CDC
					Contact Us
					800-232-4636
 Facebook Twitter Instagram LinkedIn Youtube Pinterest Snapchat
 CONTACT CDC
				Contact Us
							Call 800-232-4636
							Email Us
			ABOUT CDC
				About CDC
							Jobs
							Funding
			POLICIES
				Accessibility
							External Links
							Privacy
							Policies
							No Fear Act
							FOIA
							OIG
							Nondiscrimination
							Vulnerability Disclosure Policy
			CONNECT WITH US
				Facebook
								Twitter
								Instagram
								LinkedIn
							Youtube
								Pinterest
								Snapchat
								Email
			LANGUAGES
				Español
							繁體中文
							Tiếng Việt
							한국어
							Tagalog
							Русский
							العربية
							Kreyòl Ayisyen
							Français
							Polski
							Português
							Italiano
							Deutsch
							日本語
							فارسی
							English


U.S. Department of Health & Human Services
			Accessibility
			External Links
			Privacy
			Policies
			No Fear Act
			FOIA
			Nondiscrimination
			OIG
			Vulnerability Disclosure Policy
			USA.gov


Exit Notification / Disclaimer Policy Close
 Links with this icon  indicate that you are leaving the CDC website. The Centers for Disease Control and Prevention (CDC) cannot attest to the accuracy of a non-federal website.
				Linking to a non-federal website does not constitute an endorsement by CDC or any of its employees of the sponsors or the information and products presented on the website.
				You will be subject to the destination website's privacy policy when you follow the link.
				CDC is not responsible for Section 508 compliance (accessibility) on other federal or private website. Website Disclaimers
 Cancel Continue